Literature DB >> 35789335

Item-level psychometrics of the Ascertain Dementia Eight-Item Informant Questionnaire.

Yeajin Ham1, Suyeong Bae1, Heerim Lee1, Yaena Ha1, Heesu Choi1, Ji-Hyuk Park2, Hae Yean Park2, Ickpyo Hong2.   

Abstract

The aim of this study is to evaluate the item-level psychometrics of the Ascertain Dementia Eight-Item Informant Questionnaire (AD-8) by examining its dimensionality, rating scale integrity, item fit statistics, item difficulty hierarchy, item-person match, and precision. We used confirmatory factor analysis and the Rasch rating scale model for analyzing the data extracted from the proxy versions of the 2019 and 2020 National Health and Aging Trends Study, USA. A total of 403 participants were included in the analysis. The confirmatory factor analysis with a 1-factor model using the robust weighted least squares (WLSMV) estimator indicated a unidimensional measurement structure (χ2 = 41.015, df = 20, p = 0.004; root mean square error of approximation = 0.051; comparative fit index = 0.995; Tucker-Lewis Index = 0.993;). The findings indicated that the AD-8 has no misfitting items and no differential item functioning across sex and gender. The items were evenly distributed in the item difficulty rating (range: -2.30 to 0.98 logits). While there were floor effects, the AD-8 revealed good reliability (Rasch person reliability = 0.67, Cronbach's alpha = 0.89). The Rasch analysis reveals that the AD-8 has excellent psychometric properties that can be used as a screening assessment tool in clinical settings allowing clinicians to measure dementia both quickly and efficiently. To summarize, the AD-8 could be a useful primary screening tool to be used with additional diagnostic testing, if the patient is accompanied by a reliable informant.

Entities:  

Mesh:

Year:  2022        PMID: 35789335      PMCID: PMC9255723          DOI: 10.1371/journal.pone.0270204

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.752


Introduction

According to the World Health Organization (WHO), the world population belonging to the age group 65 years and above is expected to reach 1 billion by 2020 and 2 billion by 2050 [1]. As the birth rate decreases and life expectancy increases, demographic changes emerge worldwide, resulting in a society that is growing old and has varied socioeconomic impacts [2]. Due to this aging, geriatric chronic diseases, such as Alzheimer’s and other neurodegenerative diseases, and cardiovascular diseases, are rising exponentially [3]. Furthermore, the number of patients with dementia is expected to increase to 78 million by 2030 and 139 million by 2050, corresponding to the increase in the elderly population [1]. According to the Center for Disease Control and Prevention (CDC) data, dementia places a great socioeconomic burden on the patient and their family resulting from decreased memory, attention, reasoning, judgment, and problem-solving ability [4]. Given that dementia is not an inevitable sequela of aging, early detection and appropriate treatment to delay its onset are crucial [5]. The most prominent symptoms of dementia are memory and executive dysfunction, which are accompanied by other neuropsychiatric symptoms (NPS) and decreased ability and speed in the execution of activities of daily living (ADLs) [6]. A study reported that over 90% of patients with dementia had at least one NPS, leading to severe deterioration of the patient’s quality of life and was strongly associated with caregiver burden [7]. Hence, early detection may help reduce the family suffering and social costs through appropriate treatment and management [8]. A systematic review described the following assessment tools used to screen for dementia in a community setting: Montreal Cognitive Assessment (MoCA), Addenbrooke’s. Cognitive Examination-III (ACE-III), Saint Louis University Mental Status, and Rapid Cognitive Screen [9]. However, these assessment tools require >10 minutes for administration, which limits their use as a screening tool in clinical settings wherein the clinicians are required to complete the initial assessments quickly. The Ascertain Dementia Eight-Item Informant Questionnaire (AD-8) is a dementia screening tool demonstrating excellent correlation and concurrent validity to other screening tools and can be used as an adjunct to other tools [10, 11]. The AD-8 consists of eight items to help clinicians or healthcare providers quickly detect cognitive impairment [12]. It has a short administration time, an average of 3 minutes; the constituent items have a dichotomous response category (yes or no) and can be divided into four conceptual domains–memory, endurance, execution ability, and complex functions [10]. It is assumed that the AD-8 is a valuable tool for screening possible cognitive impairment and can be applied to clinical settings. However, so far, no study has evaluated its construct validity including item-level psychometrics. Construct validity refers to how well the evaluation tool measures the variable being evaluated [13], whereas Rasch analysis is applied to study the feasibility of an evaluation tool [14]. Rasch analysis helps establish the internal consistency and reliability of each item constituting the test [15], focusing on each question [16]. To the best of our knowledge, this methodology has not yet been applied to inspect the psychometric properties of the AD-8. Therefore, this study aimed to apply Rasch analysis to confirm the psychometrics of the AD-8. We evaluated dimensionality, rating scale integrity, item fit statistics, item difficulty hierarchy, item-person match, and precision of the AD-8. Additionally, we checked for the presence of any differential item functioning in age and sex, or floor and ceiling effects.

Materials and methods

Study settings

The data for this analysis was obtained from the proxy versions of the National Health and Aging Trends Study (NHATS) conducted in 2019 and 2020 (round 9, round10) [17, 18]. The NHATS is a health-related survey carried out annually since 2011 for older adults aged 65 years and above who are Medicare beneficiaries in the United States. The NHATS gathers critical information about the respondents, including sociodemographics, physical and cognitive functions, health status, and medication; a proxy, typically a family member, can complete the survey when the participant is not available due to cognitive impairment or health issues. We collected the observations responding to the AD-8 and excluded entries with any missing data of the questions from NHATS data of rounds 9 and 10. This study was exempt from ethical clearance by the local Institutional Review Board in Korea as the study utilized publicly available de-identified data from the NHATS.

AD-8 questionnaire

Cognitive function in the NHATS is measured by the Washington University Dementia Screening Interview, also known as the AD-8, a brief and simple screening tool that distinguishes individuals with potential dementia or mild cognitive impairment [11]. AD-8’s eight questions identify the difficulties experienced by the individuals in the last several years due to memory and cognitive impairment to indicate the risk of cognitive decline [19]. The AD-8 is an informant-based assessment and can be completed by patients, caregivers (spouse, child, etc.), or practitioners; it can be administered in person or by phone. The average administration time is <3 minutes and the interviewer is required to undergo minimal training. Additionally, the AD-8 is reported to be appropriate for primary and tertiary health care settings and community settings [20, 21]. The AD-8 consists of a 3-point rating scale, including the following responses: (1) Yes, a change, (2) No, no change, and (3) N/A, do not know. When analyzing the response using Rasch analysis, we collapsed the rating scale into a dichotomous response category: 1-point is given for each “Yes, a change” and 0 for “No, no change” and “Do not know.” A total score higher than 2 points indicates possible cognitive impairment, which requires a more precise dementia test [22]. A previous study reported that the AD-8 offers good reliability and validity with a Cronbach’s alpha of 0.84 (95%, confidence interval (CI) = 0.80–0.87) [11].

Data analyses

Unidimensionality

In the Rasch model, one of the core assumptions is a unidimensional measurement structure [23]. Before calibrating the AD-8 using the Rasch model, we conducted a confirmatory factor analysis (CFA) with a one-factor model to assess the unidimensionality assumption for the AD-8. The Chi-square test was used to evaluate the overall model fit, wherein non-significance (p > 0.05) indicated that the model fits the data [24]. Similarly, a root mean square error of approximation (RMSEA) of <0.08 is required for a good fit, whereas RMSEA <0.06 is considered an excellent fit [25]. Also, a comparative fit index (CFI) of >0.95 and Tucker–Lewis Index (TLI) of >0.95 are considered good fit [25]. In categorial data, the appropriate estimation methods are weighted least squares (WLS) or robust weighted least squares (WLSMV) [26]. We utilized the WLSMV estimiator accoriding to the PROMIS group guideline [25]. Mplus version 8.4 (LosAngeles, CA, 2012) was used for the CFA.

Local independence

We examined the local independence of all eight items on the AD-8. Local independence influences the unidimensionality of an instrument and should be checked before Rasch analysis [27]. When residual correlations among the test items are greater than 0.2, those items are considered to violate the local independence assumption [25].

Rasch analysis

Rating scale analysis

We assessed the rating scale of the AD-8 with the Rasch rating scale model using the following three crucial criteria: 1) the number of observations is greater than10 for each rating scale category; 2) rating score measures (category measures) advanced from the lowest to the highest rating score; 3) outfit mean square value (MnSq) less than 2.0 per rating scale category is required [28].

Item fit statistics

These statistics identify the misfitting items in the Rasch model [16]. We followed Wright’s guidance to assess the item fit statistics; the ideal item MnSq is 1.0 with an infit and outfit range of 0.6–1.4. Additionally, the standardized Z-value (Zstd) should be less than 2.0 (Linacre & Wright, 1993).

Item difficulty hierarchy

Item difficulty hierarchy is used to calculate the number of people who succeeded at an item from the total number of people who attempted it [16]. Item difficulty hierarchy in this study was analyzed in ascending order. A high measured value means that the item was difficult.

Differential item functioning

Subsequently, we performed differential item functioning (DIF) analysis to estimate the invariance and stability of item hierarchy among the different sex and age groups. DIF analysis is generally applied for comparing two groups when the expected performance of both groups is different [29, 30]. For example, DIF occurs when participants respond differently to individual scale items based on similar variables, such as sex and age [31]. It is known that cognitive ability is a significant factor for age-related changes [Psychol Aging. 2001 ">32-34]; according to Thacker et al., cognitive function worsens after the age of 80 years [35]. For this study, we hypothesized that the sex and age of respondents will not affect their responses to all items of the AD-8. The following criteria for determining item DIF were used: a DIF contrast of |DIF| ≥ 0.43 logits, and a p-value of ≤ 0.05 [23].

Item-person match

We also checked the item-person match that indicates the item difficulties and a person’s ability on the same interval-logit scale. A logit scale value of 0 is forthwith fixed as the average item difficulty measure for the data. The ceiling effect was accounted for when >15% of the respondents were placed at the maximum extreme score, whereas floor effects were considered when >15% of the respondents had minimum extreme scores [36].

Precision and reliability

The instrument’s precision represents the capability of the target population with the aimed items in the form of error estimates. Rasch reliability indicates the consistency of the repeatability of the instrument when used for measurements [23]. As per the Rasch model, score precision is a function of the information available and is used to estimate a given score–a given ability level. We determined precision using the person-separation reliability ratio, considering a ratio of >2.0 and Rasch reliability of 0.80 acceptable [37]. All Rasch analyses were conducted Winsteps version 4.7.0.

Results

Participants

Fig 1 illustrates the flow diagram of cohort selection. There were 4,977 observations in the NHATS round 9 databases. Among them, 273 participants responded to the AD-8 questionnaire, and after excluding 88 observations that lacked responses to any of these eight questions, 185 observations were finally selected. In the NHATS round 10 databases, we selected 297 participants from 4,389 observations by excluding observations not responding to the AD-8 questionnaire and any missing responses and/or values in sex. After merging the two datasets, 79 duplicated observations were used from recent data (round 10), and a total of 403 participants were analyzed in this study.
Fig 1

Cohort selection flow diagram.

Mathematically, a sample size of 250 subjects or more is required in the Rasch model to achieve a definitive item calibration stability (over 99% confidence) [38]. The largest group was formed by 164 people aged ≥90 years (40.69%); 108 people were aged between 85–89 years (26.80%), 72 people aged between 80–84 years (17.87%), 47 people aged 75–79 years (11.66%), and 12 people aged 70–74 years (2.98%). Finally, this study cohort included 85 (21.09%) males and 318 (78.91%) females. More detailed demographic information is described in Table 1.
Table 1

The demographic characteristics of the study participants.

Variablen(%)
Age
70–7412 (2.98)
75–7947 (11.66)
80–8472 (17.87)
85–89108 (26.80)
Over 9060 (41.96)
Sex
Male85 (21.09)
Female318 (78.91)
Race
Non-Hispanic White232 (57.57)
Non-Hispanic Black100 (24.81)
Hispanic42 (10.42)
Othersa29 (7.20)

aOthers included American Indians, Asian, Native Hawaiian, Pacific Islander, or mixed.

aOthers included American Indians, Asian, Native Hawaiian, Pacific Islander, or mixed.

Unidimensionality

CFA and local independence

The CFA with a 1-factor model for the AD-8 is presented in Fig 2. The results of a CFA indicated good model fit based on the configuration validity (χ2 = 41.015, df = 20, p = 0.004; CFI = 0.995; TLI = 0.993; RMSEA = 0.051). These results showed that the factor loadings for all sub-items were higher than 0.5. Subsequently, we examined residual correlations to determine the local independence of the AD-8 and observed that all items scored <0.2. The results of CFA using other estimation methods were shown in S1 Table.
Fig 2

The diagram of confirmatory factor analysis for the AD-8.

The two-point AD-8 rating scale fulfilled all three essential criteria necessary to employ the Rasch model.

Item fit statistics and Item difficulty hierarchy

Table 2 presents the MnSq, Zstd, and item difficulty hierarchy value of the AD-8. We found that all AD-8 items satisfied the necessary criteria for Rasch item fit. The AD-8 item with the lowest measure was “Problems with judgment,” indicated as the most challenging item in the Rasch model, whereas the “Trouble remembering appointments” items had the highest measure, meaning the easiest item in the Rasch model. Most of the items were evenly distributed for difficulty (range: −2.30 to 0.98 logits). The average item difficulty measure of the items “Forgets correct month or year” and “Trouble handling complicated financial affairs” was similar (0.30 logits and −0.09 logits, respectively).
Table 2

Item fit statistics for the Ascertain Dementia Eight-Item Informant Questionnaire (AD-8).

Item difficultyTool itemsMeasureErrorInfitOutfit
MnSqZstdMnSqZstd
Least commonly reported as a problemMost commonly reported as a problem3. Trouble remembering appointments0.97.180.96−0.440.83−0.85
8. Daily problems with thinking and/or memory0.81.170.78−2.540.59−2.67
2. Repeats the same things over and over0.66.171.120.980.720.74
5. Trouble handling complicated financial affairs0.30.160.98−0.200.95−0.31
1. Forgets correct month or year−0.09.160.92−1.000.9−0.85
6. Trouble learning how to use a tool, appliance, or gadget−0.16.160.98−0.240.91−0.76
4. Less interest in hobbies/activities−0.19.162.612.040.710.75
7. Problems with judgment−2.30.171.080.770.710.73

MnSq, mean square; Zstd, standardized z-value

MnSq, mean square; Zstd, standardized z-value As per the DIF analysis based on age and sex groups (Table 3), no DIF was found according to the sex (female vs. male) and age (70–80 years vs. >81 years) of the respondent.
Table 3

Results of the differential item functioning analyses.

Tool itemSexAge
Females (n = 318) vs. Males (n = 85)70–80 years (n = 59) vs. over 81 years (n = 344)
DIF contrastMantel–Haenszel probabilityDIF contrastMantel–Haenszel probability
1. Forgets correct month or year −0.44.4240.53.225
2. Repeats the same things over and over −1.05.056−0.37.401
3. Trouble remembering appointments 0.53.284−0.13.771
4. Less interest in hobbies/activities 0.24.9470.28.515
5. Trouble handling complicated financial affairs 0.04.872−0.68.117
6. Trouble learning how to use a tool, appliance, or gadget −0.04.8580.06.894
7. Problems with judgment 0.35.5880.21.627
8. Daily problems with thinking and/or memory −0.33.3830.04.925

DIF, differential item functioning

DIF, differential item functioning Overall, 48 of 403 (11.9%) patients reported severe cognitive problems and showed a maximum extreme score; 112 (27.8%) patients reported no cognitive problems and had a minimum extreme score. Fig 3 explains the difficulty of items and how well-assessed a person is. Except for item 7, all other AD-8 items were grouped between -1 and 1 logits. In our study, the AD-8 represented a floor effect without a ceiling effect (Fig 3).
Fig 3

Rasch person-item map for the AD-8.

Precision and reliability and Rasch principal component analysis

The Rasch person-separation value of the AD-8 was 1.41, the person-strata value was 2.21, the person-reliability value was 0.67, and the Cronbach’s alpha for the AD-8 was 0.89. A 62.6% value was observed in the Rasch principal component analysis of the AD-8; this is raw variance explained by the assessment tool. The Eigenvalue of the first contrast was 1.53.

Discussion

The AD-8 is a widely used and studied clinically-applicable screening instrument to detect dementia. The trend of research on the AD-8 is increasing based on the PubMed search engine (http://www.ncbi.nlm.nih.gov), but the item-level psychometrics of this questionnaire remains indeterminate. This study confirmed the unidimensionality of the AD-8 using CFA, and then examined its construct validity by applying the Rasch model. No misfitting items and no differential items were observed functioning across sex and gender. While we did observe a floor effect from the item-person match, the AD-8 revealed good reliability. The AD-8 evaluates how dementia symptoms affect ADLs and instrumental ADLs (IADL) rather than memory and cognitive functions. In the prodromal phase of dementia, a decrease in IADL is observed; therefore, IADL impairment is crucial for detecting dementia at an early stage [39]. Moreover, widely used assessment tools, such as MoCA and ACE-III, examine a broad range of cognitive functions, while other performance-based dementia screening tools, such as the Brief Alzheimer Screen and Brief Memory and Executive Test, require appropriate settings for the test [40]. On the other hand, the AD-8 does not require any preparation and could be used for screening dementia quickly and efficiently without any space and time constraints. The item hierarchy analysis in this study showed that the easier items were related to orientation and memory, while more challenging items were related to executive functions. Verlinden et al. (2016) summarized the hierarchical trajectory of functional decline in dementia–initially, a subjective decline in memory occurs, followed by deterioration in IADL, and lastly, basic ADL independence is lost [41]. Furthermore, another study found that functional recession in the temporoparietal association caused the central executive system dysfunctions [42]. Our results regarding the item hierarchy also found that the memory-related questions were least problematic, while the questions related to IADL and executive functions were mostly reported as a problem. We also observed floor effects from the Rasch person-item map. The floor and ceiling effects indicate limited content validity [35]; however, they are also associated with higher sensitivity [43]. A previous study of the AD-8 compared four dementia tests, including the AD-8, MMSE, participant subjective memory complaint (SMC), and the informant SMC [44]. The AD-8 had the greatest sensitivity (87.4%) but the lowest specificity (49.4%). This characteristic is supportive of the use of AD-8 as a screening instrument since other screening tests are not diagnostic of dementia but are connected to additional assessment. In line with Morris et al., our results suggest that the floor effects were shown because of the AD-8’s high sensitivity and low specificity. Additionally, the floor effect can be explained by considering that the lowest AD-8 score reflected individuals without cognitive function issues; the majority of older adults were not suspected to have dementia. In the NHATS data, all respondents in AD-8 were proxy. Proxy versions were developed for use in exceptional cases where the patient is mentally or physically not capable of reporting their health-related quality of life [45]. Proxy data may not necessarily accurately reflect the subjective characteristics of patients; however, the use of such data has many advantages, especially for people with mental health problems. Memory loss or dementia is often accompanied by anosognosia in several people, wherein the use of proxy data may be more accurate than patient-provided data [46]. A recent study compared the correlation of the MoCA and the AD-8 between the patient-reported and proxy versions [47]. The MoCA is a cognitive screening test designed to assist health professionals to detect mild cognitive impairment and Alzheimer’s disease (Copyright 2021, Ziad Nasreddine, MD). Denny et al. found a correlation between the proxy version of the AD-8 results and the MoCA scores. Notably, no correlation was found between the patient-reported version of the AD-8 and the MoCA scores [47]. This indicates that when evaluating patients with cognitive impairment, the reliability of the proxy version could be higher than that of the patient-reported version. In this study, we did not find any misfitted items in the AD-8, i.e., all eight items were appropriate for determining dementia. However, for one of the items, “Less interest in hobbies/activities?” the fit was marginal. Engaging in hobbies and physical or cognitive activities, such as playing golf, craftworks or reading books, has been found to reduce the risk of dementia [48, 49]. However, the proxy respondents may not be able to answer this accurately about the patient’s level of interest because it is more subjective than objective. It is already known that proxy respondents are more reluctant to respond to subjective questions, such as patients’ feelings or opinions [45]. Therefore, the examiner should pay careful attention when proceeding with this item in the case of the proxy version. This study had some limitations. First, we used secondary data, which may have caused bias, such as selection or measurements bias and time-lag [50]. Further, we could not get information about the missing value, and it was difficult to analyze data because there was no information on why the respondents did not answer accurately Among the AD-8 respondents in this study, 88 and 77 participants did not complete the assessment in NHATS 2019 and 2020, respectively (missing rates were 32% and 20%, respectively). Additionally, we could not control the answers (“No” and “don’t know”) that were part of the same scoring system. Nevertheless, secondary data can give broad information that can help to investigate clinical questions. We need transparency and statistical understanding when handling secondary data. Therefore, had we analyzed the data with professional help, we could have clarified better on our clinical research question. Finally, we checked only sex and age variables when analyzing DIF. Since the data were from the secondary data source, it was not easy to divide it into two different levels for other variables, such as race and educational level. Further research might need to consider other variables besides sex and age. Further statistical analyses are warranted to confirm the criterion validity using a diagnostic gold standard or test-retest reliability tests.

Conclusion

The Rasch model indicated that the AD-8 has good item-level psychometric properties for older adults aged 65 years and above who are Medicare beneficiaries in the United States. We observed that all eight items fit well and had no DIF in age and sex. The great psychometric properties of the items will allow clinicians to measure dementia in quick and efficient ways. Ultimately, the AD-8 could be a useful primary screening tool to be used with additional diagnostic testing if the patient is accompanied by a reliable informant.

Results of the confirmatory factor analysis of two estimation methods.

(DOCX) Click here for additional data file. 28 Mar 2022
PONE-D-22-03868
Item-level Psychometrics of the Ascertain Dementia Eight-Item Informant Questionnaire
PLOS ONE Dear Dr. Hong, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. ACADEMIC EDITOR:
 
Would be helpful to briefly discuss how the sample size was determined and the sufficiency of the the sample size for CFA. Moreover, in the abstract, you should include actual results from the CFA not just a narrative summary. For instance, you may include the RSMEA and CFI values. Please submit your revised manuscript by May 08 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'. A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'. An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'. If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Mohamed F. Jalloh, PhD, MPH Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf 2. We note that the grant information you provided in the ‘Funding Information’ and ‘Financial Disclosure’ sections do not match. When you resubmit, please ensure that you provide the correct grant numbers for the awards you received for your study in the ‘Funding Information’ section. 3.Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Partly ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: I Don't Know Reviewer #2: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: No Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: Dear journal editor, thank you for the opportunity. I have to review this manuscript based on my general knowledge. Perhaps it will be nice to show by an analytic expert on tool validation methods. I hope It will add value for other researchers to address such clinical issues. Reviewer #2: This is an informative study in an important area of research. Dementia is an illness of great public health concern and as th e authors have mentioned, early screening results in early management of the illness, and a reduction in family suffering and social costs. The authors can clarify a few review comments. 1. The data for the analysis was obtained from the NHATs 2019 survey, the authors report on age and sex findings in the results, it is however difficult to understand how heterogenous the study population is, based only on reported age and sex variables. 2. The authors in the results section indicate that out of 4,977 observations only 185 were selected due to missing data. Did the authors analyze if the missingness was at random, is the missing data ignorable? Such high numbers of missing data can be problematic because of bias. This means the results may not be generalizable outside of this study because the data comes from an unrepresentative sample. 3. In the discussion the authors state "According to PubMed, there is an increase in the number of studies related to AD-8,but the item-level psychometrics of this questionnaire remains indeterminate". Can the authors provide a reference for this. 4. In the study limitations the authors state "First, we used secondary data, which may have caused some bias. "Can the authors elaborate on what biases. 5. In the conclusion, the authors need to emphasize that the study substantiate the reliability and validity of the AD-8...in the selected population. Based on the small and likely homogenous sample it may be inaccurate to generalize. 6. One limitation not mentioned by the authors was that criterion validity utilizing diagnostic gold standard and test-retest reliability using repeated measures was not assessed. Perhaps a consideration for future studies. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: Yes: Mohammed Hassen (Assistant professor, Ph.D Fellow in chronic care) Reviewer #2: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.
Submitted filename: manuscript.doc Click here for additional data file. Submitted filename: feedback to authors.docx Click here for additional data file. 13 May 2022 1. Academic editor: 1) Would be helpful to briefly discuss how the sample size was determined and the sufficiency of the the sample size for CFA. Moreover, in the abstract, you should include actual results from the CFA not just a narrative summary. For instance, you may include the RSMEA and CFI values. Response: Thank you for considering our research study for publication in Plos One and for helping us make distinct, refined, and effective revisions to our manuscript. In accordance with your recommendations, we have now edited the procedure for selecting an appropriate sample size (Page8-9, Line 252-268). In our original manuscript, which made use of the NHATS round 9 data, we included 185 participants as the appropriate sample size to obtain stable item calibration with 99% confidence. However, after reviewing the comments, we have now included 297 additional participants from the recently released NHATS round 10 data. Therefore, a total of 403 participants, including 79 instances of duplicated data, were analyzed in this study, thus allowing for greater item calibration stability. Furthermore, more recent data have now been included in our analysis, and we have thus changed the overall statistical figures. However, our results have not significantly changed. Finally, we have included other CFA-related values, such as RSMEA, CFI, and TLI, in the abstract (Page 2, Line 48-52). 2. Reviewer 1 1) Dear Author, I am not such an expert on such type of tool analysis procedure. But I will try my best to maximize the outcome. It was better to tell as to why you selected this tool instead of others in your literature part and discussion section. Additionally, it was more strong evidence if you incorporate additional data (Not only 2019 Data Source). Response: Thank you for the excellent comment. In particular, more participants have been added in the analysis. The original manuscript used data from the NHATS round 9, and 185 participants were selected as the appropriate sample size, offering 99% confidence with stable item calibration with ±0.5 logits. However, after reviewing your comments, we have added 297 more participants from NHATS round 10 data, which was recently released. After merging the two datasets, a total of 403 participants were included in the final analysis, allowing for more robust and precise estimates. Furthermore, we have also included more recent data in our analysis and have thus changed the overall statistical figures. However, our results have not significantly changed compared to before (Page8-9, Line 252-268). 1) Dear author, I just put my minor comments in the main document you can get it. But as for me, I didn’t get any clue why you choose this one? Response: The AD-8 is a dementia-screening tool demonstrating good reliability and validity. The administration time is less than 3 minutes. The AD-8 test does not require any preparation, and it can be used for screening dementia in a fast and efficient manner without any space and time constraints. Therefore, the AD-8 has merits in the clinical setting; however, the item-level psychometrics have not been conducted. Also, the dichotomous response in the AD-8 is appropriate for Rasch analysis. Therefore, we applied Rasch analysis to confirm the psychometrics of the AD-8. 2) Because I didn’t get access to the full document I failed to see all over model fitness. So could you attach the summary table on your main manuscript and attach to me the raw data to see your model fitness test? Response: Thank you for your comment. Please find attached the raw data and correlation table that you requested. An estimator, ML, was not used in our study because of the nature of our data (categorical data). Instead, we have introduced and subsequently applied two appropriate estimators: weighted least squares (WLS) and robust weighted least squares (WLSMV). We described the results of WLSMV in our manuscript based on a previous study (PROMIS study) (Page 10, Line 278-279). 1) The result of CFA using WLSMV are as follows: = 41.015, df = 20, p = 0.004; CFI = 0.995; TLI = 0.993; RMSEA = 0.051 2) The result of CFA using WLS are as follows: =31.459, df=20, p=0.048; CFI=0.995; TLI=0.993; RMSEA=0.051 Also, our data were extracted from the NHATS, a health-related survey for older adults aged 65 years and above who are Medicare beneficiaries in the United States. Anyone willing to conduct research can download the raw data files after signing up (https://nhats.org/researcher/data-access). 3) Dear Author, if possible, could you please add your structural equation model to the manuscript? Response: We have now added the diagram of the confirmatory factor analysis model for the AD-8 (Figure 2) (Page 10, Line 285). 4) If I may not mistake, Rasch analysis was used for categorical data, But the AD-8 rating scale is ordinal data? Could you please clarify this one? Response: This is an excellent point. As you have mentioned, we used a dichotomous response scale for Rasch analysis. We divided answers into “Yes” or “No” by merging answers such as “No, no change” and “N/A.” We have thus revised the sentence appropriately (Page 5-6, Line 160-166). 5) Dear the author, If I am not get clear on your floor and ceiling effect results, perhaps may need to elaborate more on the result section. Response: We have explained the criterion of the ceiling and floor effect in the Methods section (Page 8, Line 238-240). Also, we have considered issues related to the floor and ceiling effect in the Discussion section (4th paragraph) (Page 16, Line 55-67). 3. Reviewer 2 1) The data for the analysis was obtained from the NHATs 2019 survey, the authors report on age and sex findings in the results, it is however difficult to understand how heterogenous the study population is, based only on reported age and sex variables. Response: Thank you for pointing this out. In this study, we hypothesized that the sex and age of the respondents do not affect their responses to every item of the AD-8. To confirm this hypothesis, we performed a differential item functioning analysis. Also, we have now added a demographic table that includes additional participant characteristics shown in Table 1 (Page 9, Line 272). 2) The authors in the results section indicate that out of 4,977 observations only 185 were selected due to missing data. Did the authors analyze if the missingness was at random, is the missing data ignorable? Such high numbers of missing data can be problematic because of bias. This means the results may not be generalizable outside of this study because the data comes from an unrepresentative sample. Response: Thank you for this comment. We do agree that the sentence we described in the “participants” session could be confusing for the reader. Not all respondents in the NHATS participated in the AD8 questionnaire. More specifically, only individuals with cognitive problems reported by their proxy participated in the AD-8. Among the 4,977 observations in the NHATS round 9 databases, 273 participants responded to the AD-8 questionnaire. After excluding 88 observations with missing data, a total of 185 responses to these eight questions were selected. In addition, we have included the recent NHATS round 10 dataset, thus adding more participants and strengthening the respective evidence. We have also refined and further clarified the data collection process (Page8-9, Line 252-268). In addition, we have now mentioned the limitation caused by the missing observations in the discussion section (Page 17, Line 95-97). 3) In the discussion the authors state "According to PubMed, there is an increase in the number of studies related to AD-8,but the item-level psychometrics of this questionnaire remains indeterminate". Can the authors provide a reference for this. Response: We appreciate your comment. We have investigated research trends on AD8 using the PubMed search engine. Therefore, this sentence has not been sourced from other studies but it is the result of our research process. To clarify this, we have revised the sentence (Page 15, Line 28-30). 4) In the study limitations the authors state "First, we used secondary data, which may have caused some bias. "Can the authors elaborate on what biases. Response: Thank you for the comment. Accordingly, we have now listed potential sources of biases that might have been caused by the use of secondary data, under limitations (Page 17, Line 93). 5) In the conclusion, the authors need to emphasize that the study substantiate the reliability and validity of the AD-8...in the selected population. Based on the small and likely homogenous sample it may be inaccurate to generalize. Response: We agree with your point. The use of the term “substantiate” in these cohort datasets is inappropriate. To clarify the same, we have specified the population and revised the sentence accordingly. (Page 18, Line 112-114). 6) One limitation not mentioned by the authors was that criterion validity utilizing diagnostic gold standard and test-retest reliability using repeated measures was not assessed. Perhaps a consideration for future studies. Response: We appreciate your comment. We have now added this information as a limitation of our study, as recommended by you (Page 17-18, Line 107-109). Submitted filename: Response to Reviewers.docx Click here for additional data file. 7 Jun 2022 Item-level Psychometrics of the Ascertain Dementia Eight-Item Informant Questionnaire PONE-D-22-03868R1 Dear Dr. Hong, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Mohamed F. Jalloh, PhD, MPH Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: The paper was much matured than the previous submission. I think it is sound for publication. Thank you ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: Yes: Mohammed Hassen Salih ********** Submitted filename: responses to plos one.docx Click here for additional data file. 10 Jun 2022 PONE-D-22-03868R1 Item-level Psychometrics of the Ascertain Dementia Eight-Item Informant Questionnaire Dear Dr. Hong: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Mohamed F. Jalloh Academic Editor PLOS ONE
  37 in total

Review 1.  Rating scales as outcome measures for clinical trials in neurology: problems, solutions, and recommendations.

Authors:  Jeremy C Hobart; Stefan J Cano; John P Zajicek; Alan J Thompson
Journal:  Lancet Neurol       Date:  2007-12       Impact factor: 44.182

2.  Reliability and Validity of the Cornell Scale for Depression in Dementia and Invariance Between Black Versus White Residents in Nursing Homes.

Authors:  Barbara Resnick; Kimberly Van Haitsma; Ann Kolanowski; Elizabeth Galik; Marie Boltz; Jeanette Ellis; Liza Behrens; Karen Eshraghi
Journal:  J Am Med Dir Assoc       Date:  2021-12-08       Impact factor: 7.802

3.  The informant AD8 is superior to participant AD8 in detecting cognitive impairment in a memory clinic setting.

Authors:  Yanhong Dong; Wan Shin Pang; Leon Ben Swie Lim; Yuan-Han Yang; John C Morris; Saima Hilal; Narayanaswamy Venketasubramanian; Christopher Li-Hsian Chen
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

4.  Trajectories of decline in cognition and daily functioning in preclinical dementia.

Authors:  Vincentius J A Verlinden; Jos N van der Geest; Renée F A G de Bruijn; Albert Hofman; Peter J Koudstaal; M Arfan Ikram
Journal:  Alzheimers Dement       Date:  2015-09-09       Impact factor: 21.566

5.  Atrial fibrillation and cognitive decline: a longitudinal cohort study.

Authors:  Evan L Thacker; Barbara McKnight; Bruce M Psaty; W T Longstreth; Colleen M Sitlani; Sascha Dublin; Alice M Arnold; Annette L Fitzpatrick; Rebecca F Gottesman; Susan R Heckbert
Journal:  Neurology       Date:  2013-06-05       Impact factor: 9.910

6.  Evaluation of cognitive impairment in older adults: combining brief informant and performance measures.

Authors:  James E Galvin; Catherine M Roe; John C Morris
Journal:  Arch Neurol       Date:  2007-05

7.  [Types and number of hobbies and incidence of dementia among older adults: A six-year longitudinal study from the Japan Gerontological Evaluation Study (JAGES)].

Authors:  Ling Ling; Taishi Tsuji; Yuiko Nagamine; Yasuhiro Miyaguni; Katsunori Kondo
Journal:  Nihon Koshu Eisei Zasshi       Date:  2020

Review 8.  Dementia prevention, intervention, and care.

Authors:  Gill Livingston; Andrew Sommerlad; Vasiliki Orgeta; Sergi G Costafreda; Jonathan Huntley; David Ames; Clive Ballard; Sube Banerjee; Alistair Burns; Jiska Cohen-Mansfield; Claudia Cooper; Nick Fox; Laura N Gitlin; Robert Howard; Helen C Kales; Eric B Larson; Karen Ritchie; Kenneth Rockwood; Elizabeth L Sampson; Quincy Samus; Lon S Schneider; Geir Selbæk; Linda Teri; Naaheed Mukadam
Journal:  Lancet       Date:  2017-07-20       Impact factor: 202.731

9.  Developing a proxy version of the Adult social care outcome toolkit (ASCOT).

Authors:  Stacey Rand; James Caiels; Grace Collins; Julien Forder
Journal:  Health Qual Life Outcomes       Date:  2017-05-19       Impact factor: 3.186

10.  Ageism in an Aging Society: The Role of Knowledge, Anxiety about Aging, and Stereotypes in Young People and Adults.

Authors:  Anna Rosa Donizzetti
Journal:  Int J Environ Res Public Health       Date:  2019-04-13       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.